However, the improvement in the area under the CDF curve when k = 4 is not as significant as when k = 3.
← all excerpts
Integration of transcriptomic data reveals lipid metabolic heterogeneity and identifies GSTO1 as a therapeutic target in acute myeloid leukemia.
1
—
—